Last reviewed · How we verify
Prevention blood clots forming in hardened blood vessels
Approved treatments
- Plavix · Generic (originally Sanofi/BMS)
Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention blood clots forming in hardened blood vessels patent landscape — cliff calendar, originator estates, attackable patents
- Prevention blood clots forming in hardened blood vessels treatment landscape brief
- Prevention blood clots forming in hardened blood vessels treatment updates RSS
Frequently asked questions about Prevention blood clots forming in hardened blood vessels
What drugs treat Prevention blood clots forming in hardened blood vessels?
Tracked treatments include Plavix.
What is the treatment for Prevention blood clots forming in hardened blood vessels?
Standard treatment for Prevention blood clots forming in hardened blood vessels includes Plavix. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention blood clots forming in hardened blood vessels patent cliff · Prevention blood clots forming in hardened blood vessels CI report
- Treatment: Plavix · Generic (originally Sanofi/BMS)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing